 Thermo Fisher operates worldwide selling medical and science laboratories products, software, and services that benefitted from the pandemic but are not beholden to it for profit and momentum. The stock gets low grades for valuation and growth but investors can potentially realize a 20 upside or more in the next 12 months. 